生命科学资讯

Appointments and advancements for Feb. 25, 2026

Financings for Feb. 25, 2026

In the clinic for Feb. 25, 2026

Other news to note for Feb. 25, 2026

Regulatory actions for Feb. 25, 2026

Covant Therapeutics patents FcRn antagonists

Blossomhill Therapeutics reports new EGFR inhibitors

PARG inhibitors disclosed in Avelos Therapeutics patent

Shanghai Meiyue Biotech patents divulge c-KIT inhibitors

Waverley Pharma synthesizes PARP-1 inhibitors

Appointments and advancements for Feb. 24, 2026

Financings for Feb. 24, 2026

In the clinic for Feb. 24, 2026

Regulatory actions for Feb. 24, 2026

Astellas and Vir in $1.3B deal for CD3 T-cell engager

Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies

Other news to note for Feb. 24, 2026

Harbour Biomed spins out newco in $1.2B CTLA-4 deal

Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push

Appointments and advancements for Feb. 24, 2026